Similar articles

• Misleading data analyses in salmeterol (SMART) study.

  Lurie P, Wolfe SM. Lurie P, et al. Lancet. 2005 Oct 8;366(9493):1261-2; discussion 1262. doi: 10.1016/S0140-6736(05)67518-6. Lancet. 2005. PMID: 16214589 No abstract available.
• Salmeterol.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 1994 Apr 29;36(921):37-9. Med Lett Drugs Ther. 1994. PMID: 7909139 No abstract available.
• Salmeterol for the treatment of asthma.

  Weinberger M. Weinberger M. Ann Allergy Asthma Immunol. 1995 Sep;75(3):209-11. Ann Allergy Asthma Immunol. 1995. PMID: 7552921 Review. No abstract available.
• Levalbuterol and racemic albuterol: are there therapeutic differences?

  Ahrens R, Weinberger M. Ahrens R, et al. J Allergy Clin Immunol. 2001 Nov;108(5):681-4. doi: 10.1067/mai.2001.119407. J Allergy Clin Immunol. 2001. PMID: 11692088 No abstract available.
• Beta-agonists, beta-blockers and obstructive airway disease.

  Madalena Esteves M. Madalena Esteves M. Eur Ann Allergy Clin Immunol. 2005 Dec;37(10):375-9. Eur Ann Allergy Clin Immunol. 2005. PMID: 16528900 Review. No abstract available.